OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Andrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 453-461
Open Access | Times Cited: 16

Showing 16 citing articles:

Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Shaomin Yan, Yu Gan, Huizhe Xu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access | Times Cited: 1

Engineering bacteria for cancer immunotherapy
Jesse G. Zalatan, Lorenzo Petrini, Roger Geiger
Current Opinion in Biotechnology (2024) Vol. 85, pp. 103061-103061
Open Access | Times Cited: 10

Advances in engineered bacteria vaccines for enhancing anti-cancer immunity
Wu Liu, Wenjing Chen, Yujie Cai, et al.
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1

Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Min Yang, Peiluan Zhong, Pengcheng Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2056-2056
Open Access

Tumor‐seeking bacterial missiles
George Cavic, Aude M. Fahrer
Immunology and Cell Biology (2025)
Closed Access

Bacteria as Precision Tools for Cancer Therapy
Carmen Michán, José Prados, Juan L. Ramos
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access

Gut Competition Dynamics of Live Bacterial Therapeutics Are Shaped by Microbiome Complexity, Diet, and Therapeutic Transgenes
Nicole Siguenza, S. E. R. Bailey, Mohammad Sadegi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Innovative Applications of Bacteria and Their Derivatives in Targeted Tumor Therapy
Denghui Zhu, Wei Pan, Heqi Li, et al.
ACS Nano (2025)
Closed Access

Microbially synthesized nanomaterials: Advances and applications in biomedicine
Junjie Pan, Hong Qian, Ya‐Yen Sun, et al.
Precision medicine and engineering. (2025), pp. 100019-100019
Open Access

Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite
Troels Holger Vaaben, Ditte Olsen Lützhøft, Andreas Koulouktsis, et al.
EMBO Reports (2025)
Open Access

Targeted Delivery of Personalized Cancer Vaccines Based on Antibody–Antigen Complexes
Yaling Zhang, Lingling Yan, He Sun, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 324-324
Open Access

Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer
Idris Vruzhaj, Marta Gambirasi, Davide Busato, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 633-633
Open Access

Engineering immunity: bacterial delivery of cancer neoantigen vaccines
Christopher D. Johnston, Jennifer A. Wargo
Trends in Immunology (2024)
Closed Access | Times Cited: 1

Surface-Functionalized Bacteria: Frontier Explorations in Next-Generation Live Biotherapeutics
Jianqing Jiang, Fanhui Kong, Qi Lei, et al.
Biomaterials (2024) Vol. 317, pp. 123029-123029
Closed Access | Times Cited: 1

Gut microbiota in cancer initiation, development and therapy
Ruyi Zhang, Xiang Zhang, Harry Cheuk-Hay Lau, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 1

Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy
Jesse Garcia Castillo, Sebastían Fernández, Timothy Campbell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top